nabumetone has been researched along with Granulocytic Leukemia, Chronic in 1 studies
Nabumetone: A butanone non-steroidal anti-inflammatory drug and cyclooxygenase-2 (COX2) inhibitor that is used in the management of pain associated with OSTEOARTHRITIS and RHEUMATOID ARTHRITIS.
nabumetone : A methyl ketone that is 2-butanone in which one of the methyl hydrogens at position 4 is replaced by a 6-methoxy-2-naphthyl group. A prodrug that is converted to the active metabolite, 6-methoxy-2-naphthylacetic acid, following oral administration. It is shown to have a slightly lower risk of gastrointestinal side effects than most other non-steroidal anti-inflammatory drugs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vural, F | 1 |
| Ozcan, MA | 1 |
| Ozsan, GH | 1 |
| Ateş, H | 1 |
| Demirkan, F | 1 |
| Pişkin, O | 1 |
| Undar, B | 1 |
1 other study available for nabumetone and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Cyclo-oxygenase 2 inhibitor, nabumetone, inhibits proliferation in chronic myeloid leukemia cell lines.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Butanones; Cell Line, Tumor; | 2005 |